Nilotinib EP Impurity A
✓
데이터 정확도 100%
연중무휴 과학적 지원
⬡
제품 품질에 대한 무관용 원칙

재고 위치

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 재고 가용성에 따라 다름

Documentation

MSDS 다운로드

샘플 COA 다운로드

포함 사항: HPLC, MASS/LC-MS, 1H NMR, FT-IR, 함량, 구조 규명 보고서(SER), 그리고 제품에 따라 추가 분석 데이터가 제공됩니다.

641571-11-1Nilotinib EP Impurity A

● 재고 있음

카탈로그 번호:VE006046
CAS 번호:641571-11-1
분자식:C11H10F3N3
분자량:241.22 g/mol

에 대한 추가 정보 CAS 641571-11-1

모약물

Nilotinib

IUPAC명

3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline

Pharmacopeial Synonyms

Nilotinib Related Compound A

동의어

Nilotinib Amino Impurity

SMILES

NC1=CC(C(F)(F)F)=CC(N2C=C(C)N=C2)=C1

InChI

NC1=CC(C(F)(F)F)=CC(N2C=C(C)N=C2)=C1

설명

Nilotinib EP Impurity A, also known as Nilotinib Related Compound A, in various pharmacopoeias, is a highly characterized standard. It meets strict regulatory requirements set by USP, EMA, JP, and BP, making it a crucial component in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Nilotinib.

References

Kondra, S. B., et al. “A Validated Stability-Indicative UPLC Method for Nilotinib Hydrochloride for the Determination of Process-Related and Degradation Impurities.” Journal of Chromatographic Science, vol. 52, no. 8, Sept. 2013, pp. 880–85, https://doi.org/10.1093/chromsci/bmt134. ‌Tanaka, Chiaki, et al. “Effects of Rifampin and Ketoconazole on the Pharmacokinetics of Nilotinib in Healthy Participants.” The Journal of Clinical Pharmacology, vol. 51, no. 1, Jan. 2011, pp. 75–83, https://doi.org/10.1177/0091270010367428. ‌

견적 요청

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url